Testing effectiveness (Phase 2)UnknownNCT03547830
What this trial is testing
Plerixafor/G-CSF as Additional Agents for Conditioning Before HSCT in CGD Patients
Who this might be right for
Chronic Granulomatous Disease
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 17